Literature DB >> 12204892

Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.

Jinbo Liu1, Jeffrey A Kern.   

Abstract

Neuregulin-1 (NRG-1) is part of a family of proteins whose members are structurally related to epidermal growth factor. NRG-1 induces cell proliferation through a high-affinity receptor complex composed of a heterodimer of human epidermal growth factor-like receptor (HER) 2 and 3. In this study, we show that NRG-1 activates the Janus kinases (JAK) and signal transducer and activator of transcription proteins (STAT). NRG-1 induced a rapid and transient increase in tyrosine phosphorylation of TYK2 and JAK3, but not JAK1 or JAK2, and induced STAT3 and STAT5 tyrosine phosphorylation. Upon phosphorylation, STAT3 translocated to the nucleus within 1 h. Activation of the JAK-STAT pathway was dependent on HER2/HER3 heterodimerization and was necessary for NRG-1-induced proliferation. Inhibition of HER2's ability to dimerize using the HER2-specific antibody 2C4 completely blocked NRG-1-induced JAK3, TYK2, STAT3, and STAT5 tyrosine phosphorylation. Blocking the JAK-STAT pathway with a specific JAK-STAT pathway inhibitor, AG490, inhibited NRG-1-induced JAK and STAT phosphorylation and cell proliferation. These data suggest that NRG-1 activates the JAK-STAT signal transduction pathway through its high-affinity receptor, the HER2/HER3 heterodimer. This pathway plays an important role in NRG-1-stimulated proliferation of pulmonary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204892     DOI: 10.1165/rcmb.4850

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

Review 1.  Janus kinase-3 dependent inflammatory responses in allergic asthma.

Authors:  Rama Malaviya; Debra L Laskin; Ravi Malaviya
Journal:  Int Immunopharmacol       Date:  2010-04-27       Impact factor: 4.932

Review 2.  Pertuzumab: in the first-line treatment of HER2-positive metastatic breast cancer.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-02-12       Impact factor: 9.546

Review 3.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

4.  Neuregulin-1β regulation of embryonic endothelial progenitor cell survival.

Authors:  Radwan N Safa; Xu-Yang Peng; Laura Pentassuglia; Chee Chew Lim; Mathias Lamparter; Cheri Silverstein; Jeremy Walker; Billy Chen; Carrie Geisberg; Antonis K Hatzopoulos; Douglas B Sawyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

Review 5.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

6.  Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system.

Authors:  Andrew V Kossenkov; Anil Vachani; Celia Chang; Calen Nichols; Shere Billouin; Wenhwai Horng; William N Rom; Steven M Albelda; Michael K Showe; Louise C Showe
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

7.  Dysfunctional ErbB2, an EGF receptor family member, hinders repair of airway epithelial cells from asthmatic patients.

Authors:  Hideki Inoue; Takeshi Hattori; Xiuxia Zhou; Emily B Etling; Brian D Modena; John B Trudeau; Fernando Holguin; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2019-01-10       Impact factor: 10.793

8.  Transcription factor ETV1 is essential for rapid conduction in the heart.

Authors:  Akshay Shekhar; Xianming Lin; Fang-Yu Liu; Jie Zhang; Huan Mo; Lisa Bastarache; Joshua C Denny; Nancy J Cox; Mario Delmar; Dan M Roden; Glenn I Fishman; David S Park
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

9.  A sequence-based approach to identify reference genes for gene expression analysis.

Authors:  Raj Chari; Kim M Lonergan; Larissa A Pikor; Bradley P Coe; Chang Qi Zhu; Timothy H W Chan; Calum E MacAulay; Ming-Sound Tsao; Stephen Lam; Raymond T Ng; Wan L Lam
Journal:  BMC Med Genomics       Date:  2010-08-03       Impact factor: 3.063

10.  Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.

Authors:  Cynthia Lopez-Haber; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2013-03-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.